Quotient Ltd. | Cash Flow

Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
10,165.00
59,059.00
33,878.00
85,069.00
82,338.00
105,386
Depreciation, Depletion & Amortization
622.00
1,294.00
2,945.00
9,448.00
10,405.00
12,767
Other Funds
-
-
-
5,040.00
-
12,862
Funds from Operations
8,146.00
32,771.00
42,698.00
63,375.00
62,793.00
79,713
Changes in Working Capital
3,766.00
6,180.00
4,275.00
7,175.00
5,625.00
4,058
Net Operating Cash Flow
4,380.00
26,591.00
46,973.00
56,200.00
68,418.00
75,655
Capital Expenditures
7,226.00
24,042.00
28,977.00
20,226.00
21,754.00
Sale of Fixed Assets & Businesses
-
-
-
-
19,741.00
Purchase/Sale of Investments
-
-
-
16,038.00
5,352.00
Net Investing Cash Flow
7,132.00
24,042.00
28,977.00
36,264.00
3,339.00
Issuance/Reduction of Debt, Net
11,834.00
195.00
14,258.00
44,879.00
1,692.00
Net Financing Cash Flow
14,594.00
85,074.00
85,648.00
56,542.00
83,292.00
Net Change in Cash
2,973.00
30,333.00
6,575.00
39,346.00
15,411.00
Free Cash Flow
11,606.00
50,445.00
75,879.00
76,355.00
90,022.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
649.00
44
Other Sources
94.00
-
-
-
-
Change in Capital Stock
2,760.00
84,879.00
71,390.00
16,703.00
84,984.00
Exchange Rate Effect
109.00
4,108.00
3,123.00
3,424.00
2,802.00

About Quotient

View Profile
Address
B1, Business Park Terre Bonne
Eysins Vaud 1262
Switzerland
Employees -
Website http://www.quotientbd.com
Updated 07/08/2019
Quotient Ltd. operates as a diagnostics company. It provides immunohematology products to hospitals and blood banks. The company develops, manufactures and sells conventional reagent products to equipment manufacturers.